Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | XBP1 | P17861 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid SCHEMBL15775512 | 0.98 | CYP2C19 (0.42) | CYP2C19TSHRELANEALDH1A1LMNA | |
| SCHEMBL645426 | 0.97 | TSHR (0.43) | CYP2C19TSHRELANEALDH1A1LMNA | |
| SCHEMBL916115 | 0.95 | TSHR (0.45) | CYP2C19TSHRELANEALDH1A1LMNA | |
| SCHEMBL646900 | 0.93 | TSHR (0.43) | CYP2C19TSHRELANEALDH1A1LMNA | |
| SCHEMBL645585 | 0.93 | TSHR (0.43) | CYP2C19TSHRELANEALDH1A1LMNA | |
| SCHEMBL1079138 | 0.90 | CYP2C19 (0.42) | CYP2C19TSHRELANEALDH1A1LMNA | |
| Acrylic Acid SCHEMBL2129070 | 0.87 | CYP2C19 (0.40) | CYP2C19TSHRELANEALDH1A1LMNA | |
| SCHEMBL8064810 | 0.87 | CYP2C19 (0.51) | CYP2C19ELANEALDH1A1LMNAKMT2A | |
| SCHEMBL8064815 | 0.87 | CYP2C19 (0.51) | CYP2C19ELANEALDH1A1LMNAKMT2A | |
| SCHEMBL14842784 | 0.86 | TSHR (0.50) | TSHRALDH1A1LMNAKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080025934-A1 | Cosmetic composition combining a copolymer, a non-volatile oil and a glossy oil | L'OREAL (FR) | 2008-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080025934-A1 | Cosmetic composition combining a copolymer, a non-volatile oil and a glossy oil | CUTA, GRM1, MGLL | CYP2C19 478/4885TSHR 777/4885ELANE 1207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.